← ANALYSTS · TIPRANKS
Leland Gershell · Oppenheimer
Hits
40%
195 of 493 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+6.2%
Over a year after the rating, TipRanks’ measure
Our companies rated now
18
Buy / hold / sell: 17 / 1 / 0
Upside of the analyst’s targets
+367.4%
Average over 17 current targets, to the last price
The market’s answer to the ratings
+4.0%
Day-0 move against SPY in the rating’s direction, average over 10 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks 08:55 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,100 → $1,038−5.6% | +26.7% | −1.5%next day −1.2% | ↗ |
| Oct 6on TipRanks 08:30 | CGENCompugen · $202M | Reiterated | Buy | $4.00 | +104.1% | −4.4%next day −2.9% · 5 days −10.7% | ↗ |
| Sep 29on TipRanks Sep 30 03:50 | OCGNIWMOcugen · $276M | Reiterated | Buy | $10.00 | +1,182.1% | +6.0%next day −5.3% · 5 days −6.5% | ↗ |
| Sep 23on TipRanks 09:10 | LXEOIWMLexeo Therapeutics, Inc. · $227M | Reiterated | Buy | $20.00 | +657.6% | −12.8%next day −3.6% · 5 days −3.3% | ↗ |
| Sep 2on TipRanks 08:30 | ASNDAscendis Pharma · $13.9B | Reiterated | Buy | $304 → $312+2.6% | +38.5% | +2.3%next day +0.4% · 5 days −1.3% | ↗ |
| Aug 25on TipRanks Aug 26 04:55 | CAPRIWMCapricor Therapeutics · $423M | Upgrade | Buy | $54.00 | +704.8% | +21.6%next day +12.9% · 5 days +21.3% | ↗ |
| Aug 25on TipRanks 07:50 | SPRBIWMSpruce Biosciences · $119M | Reiterated | Buy | $230 | +480.1% | +7.8%next day −3.1% · 5 days −11.8% | ↗ |
| Aug 18on TipRanks 07:50 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,037 → $1,100+6.1% | +34.3% | +1.2%next day +3.8% · 5 days +2.9% | ↗ |
| Aug 14on TipRanks 08:15 | OKURIWMOnKure Therapeutics · $91M | Reiterated | Buy | $30.00 → $14.00−53.3% | +566.7% | +2.5%next day +3.5% · 5 days +0.1% | ↗ |
| Aug 11on TipRanks 07:55 | PALIIWMPalisade Bio · $268M | Reiterated | Buy | $8.00 | +467.4% | +2.2%next day −8.7% · 5 days −4.3% | ↗ |
| Aug 7on TipRanks 08:45 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | $18.00 | +83.3% | −0.6%next day −3.3% · 5 days +16.2% | ↗ |
| Aug 7on TipRanks 08:45 | LGNDIWMLigand Pharma · $6.0B | Reiterated | Buy | $326 | +10.3% | −2.9%next day +0.9% · 5 days +0.1% | ↗ |
| Aug 7on TipRanks 08:45 | IMVTIWMImmunovant · $5.8B | Reiterated | Buy | $54.00 | +102.0% | −0.1%next day −0.1% · 5 days +4.3% | ↗ |
| Aug 7on TipRanks 08:20 | TRVIIWMTrevi Therapeutics · $1.7B | Reiterated | Buy | $24.00 → $25.00+4.2% | +110.4% | −0.6%next day −3.8% · 5 days −0.7% | ↗ |
| Aug 7on TipRanks 08:15 | BMRNBioMarin Pharmaceutical · $10.8B | Assigned | Buy | $95.00 → $97.00+2.1% | +77.4% | +3.2%next day +8.0% · 5 days +5.2% | ↗ |
| Aug 6on TipRanks 08:30 | URGNIWMUrogen Pharma · $1.8B | Reiterated | Buy | $50.00 → $60.00+20.0% | +73.6% | −1.6%next day +2.4% · 5 days +4.3% | ↗ |
| Jun 15on TipRanks 07:50 | SABSIWMSAB Biotherapeutics · $236M | Reiterated | Buy | $14.00 | +453.4% | +15.4%next day −5.6% · 5 days +1.8% | ↗ |
| May 20on TipRanks 07:50 | TARAIWMProtara Therapeutics · $142M | Reiterated | Buy | $25.00 → $28.00+12.0% | +1,106.9% | +8.7%next day +4.2% · 5 days −2.0% | ↗ |
| Nov 4on TipRanks Nov 5 04:55 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Downgrade | Hold | — | — | −6.5%next day −5.6% · 5 days −6.0% | ↗ |
| Oct 14on TipRanks 08:45 | CGENCompugen · $202M | Reiterated | Buy | $4.00 | +104.1% | −5.7%next day −2.8% · 5 days −18.0% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗